BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Manganotti P, Pesavento V, Buoite Stella A, Bonzi L, Campagnolo E, Bellavita G, Fabris B, Luzzati R. Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2. J Neurovirol 2020;26:605-6. [PMID: 32529516 DOI: 10.1007/s13365-020-00858-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Uncini A, Vallat JM, Jacobs BC. Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic. J Neurol Neurosurg Psychiatry 2020;91:1105-10. [PMID: 32855289 DOI: 10.1136/jnnp-2020-324491] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 27.0] [Reference Citation Analysis]
2 Sullivan BN, Fischer T. Age-Associated Neurological Complications of COVID-19: A Systematic Review and Meta-Analysis. Front Aging Neurosci 2021;13:653694. [PMID: 34408638 DOI: 10.3389/fnagi.2021.653694] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Tran C, Drury B, Yuen HW, Rosenthal J, Neeki MM. Miller-Fisher Syndrome Presenting as Facial Diplegia With COVID-19 Co-Infection. Cureus 2021;13:e17060. [PMID: 34522538 DOI: 10.7759/cureus.17060] [Reference Citation Analysis]
4 Kajani S, Kajani R, Huang CW, Tran T, Liu AK. Miller Fisher Syndrome in the COVID-19 Era - A Novel Target Antigen Calls for Novel Treatment. Cureus 2021;13:e12424. [PMID: 33409112 DOI: 10.7759/cureus.12424] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Manganotti P, Bellavita G, Tommasini V, D Acunto L, Fabris M, Cecotti L, Furlanis G, Sartori A, Bonzi L, Buoite Stella A, Pesavento V. Cerebrospinal fluid and serum interleukins 6 and 8 during the acute and recovery phase in COVID-19 neuropathy patients. J Med Virol 2021;93:5432-7. [PMID: 33951196 DOI: 10.1002/jmv.27061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Biswas S, Ghosh R, Mandal A, Pandit A, Roy D, Sengupta S, De K, Swaika BC, Benito-León J. COVID-19 Induced Miller Fisher Syndrome Presenting With Autonomic Dysfunction: A Unique Case Report and Review of Literature. Neurohospitalist 2022;12:111-6. [PMID: 34950397 DOI: 10.1177/19418744211016709] [Reference Citation Analysis]
7 Salari M, Zaker Harofteh B, Etemadifar M, Sedaghat N, Nouri H. Movement Disorders Associated with COVID-19. Parkinsons Dis 2021;2021:3227753. [PMID: 34790346 DOI: 10.1155/2021/3227753] [Reference Citation Analysis]
8 Martins-Filho PR, Pereira de Andrade AL, Pereira de Andrade AJ, Moura da Silva MD, de Souza Araújo AA, Nunes PS, Santos VS, Ferreira LC, de Aquino Neves EL, Quintans-Júnior LJ. Miller Fisher Syndrome in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Systematic Review. J Clin Neurol 2021;17:541-5. [PMID: 34595862 DOI: 10.3988/jcn.2021.17.4.541] [Reference Citation Analysis]
9 Hasan I, Saif‐ur‐rahman K, Hayat S, Papri N, Jahan I, Azam R, Ara G, Islam Z. Guillain‐Barré syndrome associated with SARS‐CoV ‐2 infection: A systematic review and individual participant data meta‐analysis. J Peripher Nerv Syst 2020;25:335-43. [DOI: 10.1111/jns.12419] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
10 Kuang W, Desai P, Voloshko A, Jayasekara D. COVID-19-Associated Miller Fisher Syndrome With Long Latency Period: A Case Report. Cureus. [DOI: 10.7759/cureus.24638] [Reference Citation Analysis]
11 Abu-Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M. Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J Neurol 2021;268:1133-70. [PMID: 32840686 DOI: 10.1007/s00415-020-10124-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 28.0] [Reference Citation Analysis]
12 Manganotti P, Bellavita G, D'Acunto L, Tommasini V, Fabris M, Sartori A, Bonzi L, Buoite Stella A, Pesavento V. Clinical neurophysiology and cerebrospinal liquor analysis to detect Guillain-Barré syndrome and polyneuritis cranialis in COVID-19 patients: A case series. J Med Virol 2021;93:766-74. [PMID: 32662899 DOI: 10.1002/jmv.26289] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 14.0] [Reference Citation Analysis]
13 Ariño H, Heartshorne R, Michael BD, Nicholson TR, Vincent A, Pollak TA, Vogrig A. Neuroimmune disorders in COVID-19. J Neurol 2022. [PMID: 35353232 DOI: 10.1007/s00415-022-11050-w] [Reference Citation Analysis]
14 Sharifian-Dorche M, Huot P, Osherov M, Wen D, Saveriano A, Giacomini PS, Antel JP, Mowla A. Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic. J Neurol Sci 2020;417:117085. [PMID: 32871412 DOI: 10.1016/j.jns.2020.117085] [Cited by in Crossref: 47] [Cited by in F6Publishing: 52] [Article Influence: 23.5] [Reference Citation Analysis]
15 Tawakul AA, Al-Doboke AW, Altayyar SA, Alsulami SA, Alfahmi AM, Nooh RT. Guillain-Barré Syndrome in the COVID-19 Pandemic. Neurol Int 2021;14:34-48. [PMID: 35076589 DOI: 10.3390/neurolint14010003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Chan JL, Murphy KA, Sarna JR. Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review. J Neurol 2021. [PMID: 33616739 DOI: 10.1007/s00415-021-10458-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
17 Abdullahi A, Candan SA, Soysal Tomruk M, Elibol N, Dada O, Truijen S, Saeys W. Is Guillain-Barré Syndrome Associated With COVID-19 Infection? A Systemic Review of the Evidence. Front Neurol 2020;11:566308. [PMID: 33519663 DOI: 10.3389/fneur.2020.566308] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Manganotti P, Furlanis G, Ajčević M, Moras C, Bonzi L, Pesavento V, Buoite Stella A. Intravenous immunoglobulin response in new-onset refractory status epilepticus (NORSE) COVID-19 adult patients. J Neurol 2021. [PMID: 33709220 DOI: 10.1007/s00415-021-10468-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
19 Aladawi M, Elfil M, Abu-Esheh B, Abu Jazar D, Armouti A, Bayoumi A, Piccione E. Guillain Barre Syndrome as a Complication of COVID-19: A Systematic Review. Can J Neurol Sci 2021;:1-11. [PMID: 33949300 DOI: 10.1017/cjn.2021.102] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Finsterer J. SARS-CoV-2 associated Miller-Fisher syndrome or polyneuritis cranialis. Environ Sci Pollut Res Int 2021;28:46082-4. [PMID: 34117541 DOI: 10.1007/s11356-021-14797-3] [Reference Citation Analysis]
21 Li Z, Li X, Shen J, Chan MTV, Wu WKK. Miller Fisher syndrome associated with COVID-19: an up-to-date systematic review. Environ Sci Pollut Res Int 2021;28:20939-44. [PMID: 33677662 DOI: 10.1007/s11356-021-13233-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
22 Andalib S, Biller J, Di Napoli M, Moghimi N, McCullough LD, Rubinos CA, O'Hana Nobleza C, Azarpazhooh MR, Catanese L, Elicer I, Jafari M, Liberati F, Camejo C, Torbey M, Divani AA. Peripheral Nervous System Manifestations Associated with COVID-19. Curr Neurol Neurosci Rep. 2021;21:9. [PMID: 33586020 DOI: 10.1007/s11910-021-01102-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
23 Halpert G, Shoenfeld Y. SARS-CoV-2, the autoimmune virus. Autoimmun Rev 2020;19:102695. [PMID: 33130000 DOI: 10.1016/j.autrev.2020.102695] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 19.0] [Reference Citation Analysis]
24 Novelli L, Motta F, De Santis M, Ansari AA, Gershwin ME, Selmi C. The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature. J Autoimmun 2021;117:102592. [PMID: 33401171 DOI: 10.1016/j.jaut.2020.102592] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
25 Sansone P, Giaccari LG, Aurilio C, Coppolino F, Esposito V, Fiore M, Paladini A, Passavanti MB, Pota V, Pace MC. Post-Infectious Guillain-Barré Syndrome Related to SARS-CoV-2 Infection: A Systematic Review. Life (Basel) 2021;11:167. [PMID: 33670000 DOI: 10.3390/life11020167] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
26 Buoite Stella A, Manganotti P, Furlanis G, Accardo A, Ajčević M. Return to school in the COVID-19 era: considerations for temperature measurement. J Med Eng Technol 2020;44:468-71. [PMID: 32990119 DOI: 10.1080/03091902.2020.1822941] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]